The Rising Geriatric Population to boost Venous Thromboembolism (VTE) Market Growth

 

Venous Thromboembolism (VTE) Market

Venous Thromboembolism (VTE) Market, By Product (Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices), Type (Deep Vein Thrombosis, Pulmonary Embolism, Others), Treatment (Anti-Clotting Medications, Mechanical Devices, Thrombolytic Therapy, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Venous Thromboembolism (VTE) Market is estimated to be valued at US$ 1.53 billion in 2022 and is expected to exhibit a CAGR of 3.7 % over the forecast period as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Venous Thrombosis and Pulmonary Embolism (VT/PE) are usually not analyzed and severe, however preventable clinical problems. Venous thrombosis (VT) is a health problem that takes place while a blood clot occurs in a deep vein. These blood clots generally develop in the lower extremist, thigh, or pelvis, however they can also take place in the arm. It is essential to know regarding the Thromboembolism (VTE) as it can occur to anybody and can lead to severe illness, debility, and in some conditions, fatality.

Competitive Landscape:

Key players involved in the growth of global Venous Thromboembolism (VTE) Market are Pfizer Inc., Changzhaou Qianhong Bio-pharma Co., ltd., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., F. Hoffmann-La Roche Ltd., Hikma Pharmaceuticals PLC., Fresenius Kabi AG., Janssen Global Services, LLC., Aspen Holdings., Novartis AG and Mylan N.V.

Market Key Drivers:

Rising geriatric population across the globe is expected to augment the growth of the global Venous Thromboembolism (VTE) Market. For instance, as per the WHO, the geriatric population across the globe is expected to reach over 2 billion by 2050.

Increasing number of orthopedic surgeries across the globe is projected to propel the growth of global Venous Thromboembolism (VTE) Market. For instance, as per a survey around 22.3 million orthopedic surgeries are performed across the globe.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Venous Thromboembolism (VTE) Market due to the surge in pandemic which has led to strict imposition of lockdown and shutdown. The delay in surgeries and closure of the clinics along with restrictions on movement of people and visits to hospitals to curb the spread of virus has impeded the market growth.

Key Takeaways:

The global Venous Thromboembolism (VTE) Market is expected to exhibit a CAGR of 3.7 % during the forecast period owing to the rising approvals and product launches. For instance, In May 2019, U.S. FDA approved Pfizer, Inc. for FRAGMIN, which is a dalteparin sodium to decrease the reappearance of VTE in infants above one month.

Among regions, North America, Asia Pacific and Europe anticipated to witness robust growth in the global Venous Thromboembolism (VTE) Market due to rising geriatric population, increasing orthopedic surgeries and rising approvals and product launches. For instance, as per CDC around 60,000 to 100,000 people die due to Venous Thromboembolism (VTE).

Comments

Post a Comment

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today...
Read more

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi...
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man...
Read more